COMMUNIQUÉS West-GlobeNewswire

National Research Corporation Declares Quarterly Dividend

13/02/2019 - 23:00

Lincoln, Nebraska, Feb. 13, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 (nineteen cents) per share [...]

BeiGene to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019 and Host Investor Event in Hong Kong

13/02/2019 - 22:30

CAMBRIDGE, Mass., and BEIJING, China, Feb. 13, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical disease

13/02/2019 - 22:24

Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO Fascioliasis, commonly known as liver fluke infestation, is estimated [...]

EyePoint Pharmaceuticals Secures Up to $60 Million Debt Facility

13/02/2019 - 22:15

– Provides support for the product launches of YUTIQ™ and DEXYCU™ – WATERTOWN, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to [...]

Adverum to Present at the 8th Annual SVB Leerink Global Healthcare Conference

13/02/2019 - 22:10

MENLO PARK, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the [...]

Akcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results Webcast

13/02/2019 - 22:05

Webcast scheduled for Tuesday, February 26th at 4:30 p.m. Eastern Time BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that [...]

Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results on February 27, 2019

13/02/2019 - 22:05

BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK ), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]

ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018

13/02/2019 - 22:05

PORTLAND, Maine, Feb. 13, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company that develops, manufactures and markets scientifically-proven and [...]

AIT Therapeutics Reports Financial Results for Fiscal Third Quarter 2019

13/02/2019 - 22:05

Announced transformational partnership agreement with Circassia Pharmaceuticals PMA filing for treatment of PPHN on track for second quarter calendar 2019 Completed treatment safely of a compassionate use NTM patient at [...]

Myriad Genetics to Present at Multiple Upcoming Healthcare Conferences

13/02/2019 - 22:05

SALT LAKE CITY, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced that it will be presenting at multiple upcoming healthcare [...]

DBV Technologies Provides Update on Regulatory Status of Viaskin Peanut for the Treatment of Peanut-Allergic Children 4 to 11 Years of Age

13/02/2019 - 22:00

Montrouge, France, February 13, 2019 DBV Technologies Provides Update on Regulatory Status of Viaskin Peanut for the Treatment of Peanut-Allergic Children 4 to 11 Years of Age Progress made to date to enable BLA [...]

DBV Technologies fait le point sur le parcours réglementaire de Viaskin Peanut pour le traitement des enfants âgés de 4 à 11 ans allergiques à l’arachide

13/02/2019 - 22:00

Montrouge, France, le 13 février (22 : 00 CET) 2019 DBV Technologies fait le point sur le parcours réglementaire de Viaskin Peanut pour le traitement des enfants âgés de 4 à 11 ans allergiques à l’arachide Des progrès [...]

Canopy Rivers to Report Third Quarter Fiscal 2019 Financial Results

13/02/2019 - 20:15

TORONTO, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ”) (TSXV: RIV) will report its third quarter fiscal 2019 financial results after markets close on Wednesday February 27, 2019. The Company’s [...]

ICC Hemp Acquisitions Bolsters European Supply Chain, Speeds Extraction -- CFN Media

13/02/2019 - 18:25

SEATTLE, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Media Statement from Amedisys Commending the Home Health Payment Innovation Act

13/02/2019 - 18:16

BATON ROUGE, La., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, commends bipartisan legislation to preserve and expand [...]

Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 8, 2019

13/02/2019 - 17:12

Company management to host a webcast and conference call to provide a business update and review financial results at 8:00 a.m. ET WALTHAM, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: [...]

Vistin Pharma ASA : Invitation to Q4 conference call

13/02/2019 - 16:46

Oslo, Norway, 13 February 2019 Vistin Pharma ASA will release its fourth quarter 2018 results on Tuesday 19 February 2019. Reference is also made to the business updates from the company on 4 January and 8 January. [...]

The Alliance for Regenerative Medicine Releases Agenda for 2019 Cell & Gene Meeting on the Mediterranean

13/02/2019 - 16:03

WASHINGTON, D.C, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader [...]

Trading in Novo Nordisk shares by board members, executives and associated persons on 12 February 2019

13/02/2019 - 16:02

Bagsværd, Denmark, 13 February 2019 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]